Clinical Trial: SAFELY RULING OUT DEEP VEIN THROMBOSIS IN PREGNANCY WITH THE LEFt SCORE AND TRIMESTER-ADJUSTED D-DIMER CUTOFFS (the PREG-DVT Study): A PROSPECTIVE COHORT STUDY.

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07884981) titled 'SAFELY RULING OUT DEEP VEIN THROMBOSIS IN PREGNANCY WITH THE LEFt SCORE AND TRIMESTER-ADJUSTED D-DIMER CUTOFFS (the PREG-DVT Study): A PROSPECTIVE COHORT STUDY.' on Oct. 13.

Brief Summary: Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism (PE), is a leading cause of maternal morbidity and mortality in high-income countries.1 DVT is suspected in pregnancy greater than 10 times more often than it is confirmed.2 The overlap between physiological symptoms of pregnancy (e.g. leg edema and calf, thigh and groin discomfort) and those of DVT often leads to referral for investigation of DVT, especially ...